Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML)

被引：1
|
作者：
LeBlanc, Francis [1 ]
Bennett, Josh [2 ]
Choi, Kwangmin [3 ]
Starczynowski, Daniel T. [4 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[3] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] ANALYSIS OF THE EFFECTIVENESS OF THE USE OF AZACITIDINE-VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN RECOVERY / REFRACTORY: EXPERIENCE IN OUR CENTER
    Ma Victoria, Verdugo Cabeza De Vaca
    Plaza Virginia, Olivencia
    Prados Clara, Garrido
    Cuenca Araceli, Salamanca
    HAEMATOLOGICA, 2021, 106 (10) : 213 - 214
  • [32] High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia
    Matsuda, Kensuke
    Yoshida, Takashi
    Sugimoto, Koichi
    ANNALS OF HEMATOLOGY, 2023, 102 (04) : 971 - 972
  • [33] High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia
    Kensuke Matsuda
    Takashi Yoshida
    Koichi Sugimoto
    Annals of Hematology, 2023, 102 : 971 - 972
  • [34] Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/ refractory FLT3mut acute myeloid leukemia
    Fu, Qiang
    Wang, Yunqi
    Liu, Hongtao
    Gao, Haitao
    Sun, Wei
    Jiang, Qian
    Jiang, Hao
    Liu, Kaiyan
    Huang, Xiaojun
    Tang, Feifei
    LEUKEMIA RESEARCH, 2024, 145
  • [35] A CASE OF RELAPSED REFRACTORY ACUTE MYELOID LEUKEMIA WHO WAS ABLE TO BE TREATED AT HOME WITH VENETOCLAX/AZACITIDINE COMBINATION THERAPY
    Yamashita, Yoshiharu
    Hino, Moeko
    Okunushi, Tomoko
    Aoki, Takahiro
    Chikaraishi, Koji
    Hamada, Hiromichi
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [36] Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia
    Vinod Pullarkat
    Keith W. Pratz
    Hartmut Döhner
    Christian Recher
    Michael J. Thirman
    Courtney D. DiNardo
    Pierre Fenaux
    Andre C. Schuh
    Andrew H. Wei
    Arnaud Pigneux
    Jun-Ho Jang
    Gunnar Juliusson
    Yasushi Miyazaki
    Dominik Selleslag
    Martha L. Arellano
    Chenglong Liu
    Jean A. Ridgeway
    Jalaja Potluri
    Jovita Schuler
    Marina Konopleva
    Blood Cancer Journal, 15 (1)
  • [37] A New Class of Synthetic Type-B Polycyclic Polyprenylated Acylphloroglucinols (PPAP-B) Overcomes Venetoclax-Resistance in Acute Myeloid Leukemia (AML)
    Kampa, Leonie Elisabeth
    Bleisch, Anton
    Peslalz, Philipp
    Schittenhelm, Marcus Matthias
    Plietker, Bernd
    Kampa-Schittenhelm, Kerstin Maria
    BLOOD, 2023, 142
  • [38] Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)
    Arslan, Shukaib
    Zhang, Jianying
    Dhakal, Prajwal
    Moran, Jenna A.
    Naidoo, Nuthana
    Story, Jennifer Lombardi
    Pullarkat, Vinod A.
    Stein, Anthony S.
    Marcucci, Guido
    Yaghmour, George
    Bhatt, Vijaya R.
    Fathi, Amir T.
    Aldoss, Ibrahim
    BLOOD, 2020, 136
  • [39] Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy
    Pei, Shanshan
    Pollyea, Daniel A.
    Gustafson, Annika
    Minhajuddin, Mohammad
    Stevens, Brett M.
    Ye, Haobin
    Inguva, Anagha
    Amaya, Maria L.
    Krug, Anna
    Jones, Courtney L.
    Adane, Biniam
    Winters, Amanda
    Khan, Nabilah
    Ponder, Jessica
    Schowinsky, Jeffrey
    Hammes, Andrew
    Abbott, Diana
    Myers, Jason R.
    Ashton, John M.
    Gutman, Jonathan A.
    Purev, Enkhtsetseg
    Ramsey, Haley E.
    Savona, Michael R.
    Fesik, Stephen W.
    Smith, Clayton
    Jordan, Craig T.
    BLOOD, 2019, 134
  • [40] Molecular Profiling of Response and Resistance to Venetoclax-Decitabine Therapy in Acute Myeloid Leukemia
    Khasawneh, Abdullah
    Paran, Faith Jessica
    Oyama, Rieko
    Maiti, Abhishek
    Abbas, Hussein A.
    Wang, Bofei
    Desai, Poonam N.
    Hayes, Kala
    Harman, Joe R.
    Su, Xiaoping
    DiNardo, Courtney D.
    Andreeff, Michael
    Milne, Thomas A.
    Konopleva, Marina Y.
    Tabe, Yoko
    BLOOD, 2023, 142
12345